查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363199

細胞計數市場規模、佔有率和趨勢分析報告：按產品、用途、最終用途、地區和細分市場進行預測，2023-2030年

Cell Counting Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Accessories), By Application (Complete Blood Count, Stem Cell Research), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

細胞計數市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，2023年至2030年，全球細胞計數市場規模預計將以8.2%的年複合成長率成長，2030年達到154.6億美元。

癌症、愛滋病毒和阿茲海默症等慢性疾病盛行率的上升，推動該行業的成長。這些疾病的患病率增加推動臨床研究活動的激增，導致對細胞計數設備和消耗品的需求激增。政府推動細胞治療藥物開發的配合措施（其中細胞計數發揮關鍵作用），擴大市場成長前景。

成長主要是由於研究機構與各種公共和私人組織之間越來越多的合作來促進研究和發展。在未來年度中，將看到越來越多的指南和建議向公共和私人實驗室提案，以確保高品質標準並促進準確結果的產生。這可能會提高設備的採用率。例如，2021年 5月，國際幹細胞協會更新了細胞治療和研發指南。提案的指南將重點關注研發的各個階段，並提高臨床前研究的品質。

這些設備的技術進步也擴大了市場的成長前景。分化細胞計數的一項有前途的技術進展是能夠以更高的精度執行原始細胞識別、免疫血小板計數、原始細胞檢測、網狀紅血球分級分離和幹細胞計數。 CD4+T 細胞計數技術的出現已證明作為免疫反應的指標非常有用，並已用於評估抗逆轉錄病毒病毒治療 (ARV) 的成功或失敗。市面上有專用用於計數 CD4+ 和 CD8+ T 細胞的細胞儀，例如 Becton Dickinson 的 FACSCount，它是基於 T 細胞計數技術。

COVID-19 大流行預計將對行業成長產生積極影響。住院 COVID-19 患者的白血球數與患者死亡率有顯著相關。白血球數越高，越應重視COVID-19的治療。細胞計數對於罹患的患者的重要性日益增加，促進了該行業在大流行期間的成長。

增強型資訊科學解決方案和改進的影像分析儀器（如光學和螢光顯微鏡）的市場開拓推動該市場的成長前景。這些儀器擴大在新興經濟體中常見的低試樣處理通量實驗室和資源有限的環境中採用，擴大了該行業的成長範圍。

另一方面，熟練專業人員數量有限是限制市場成長的重要因素。熟練專業人員的短缺是由於缺乏培訓設施和高昂的培訓成本。為了改善這種情況，敦促行業公司參與為這些公司開發的軟體創建培訓計劃，並鼓勵醫療保健專業人員和研究人員操作細胞計數軟體。此外，這些軟體工具缺乏標準化也對研究人員和醫療保健專業人員產生了重大限制，因為每個軟體都有不同的使用者介面。

細胞計數市場報告亮點

  • 依產品分類，消耗品及配件領域預計在2022年佔據最大的收益佔有率，達到 54.14%，並在預測期內以 8.4%的年複合成長率成長最快。
  • 在消耗品及配件領域，試劑佔2022年最大的收益佔有率，為56.3%。這一巨大的收益佔有率是由重複購買這些用於光強度、流式細胞儀和自動細胞計數的產品所推動的。
  • 預計微孔板細分市場在預測期內將以最快的年複合成長率擴張。微孔板通常用於分析濃度非常低的樣品。由於在分析新樣品時需要重複使用新板以防止污染，微孔板的消耗量不斷增加。
  • 在設備領域，自動細胞計數器預計在預測期內將出現指數級成長。由於檢查時間更短、錯誤率更低以及操作員之間的差異等優點，對自動化計數器的需求預計將進一步增加。
  • 依用途來看，全血球計數領域佔最大收益佔有率，2022年將達59.1%。如此大的收益佔有率是由於血液疾病的發生率不斷增加。
  • 在最終用途領域，由於政府措施促進各種毒理學研究的研發，研究和學術機構在2022年佔據了最大的收益佔有率，達到 39.6%。
  • 預計製藥和生物技術公司在預測期內將以 9.0%的年複合成長率實現最快成長。
  • 由於對醫學和癌症研究的日益關注，北美地區佔據了最大的收益佔有率，超過 37.6%。
  • 由於眾多臨床研究機構和生物製藥公司的存在，預計亞太地區在預測期內將以 10.3%的年複合成長率快速成長。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 細胞計數市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 產業價值鏈分析
    • 贖回框架
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 細胞計數市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 細胞計數市場：依產品類型估算與趨勢分析

  • 細胞計數市場：要點
  • 細胞計數市場：2022年和2030年趨勢和市場佔有率分析
  • 裝置
  • 消耗品及配件

第5章 細胞計數市場：依用途估算和趨勢分析

  • 細胞計數市場：要點
  • 細胞計數市場：2022年和2030年趨勢和市場佔有率分析
  • 血液常規檢查
  • 幹細胞研究
  • 細胞療法
  • 生物加工
  • 毒理學
  • 其他

第6章 細胞計數市場：區域估計與趨勢分析

  • 區域展望
  • 依地區分類的細胞計數市場：主要市場要點
  • 北美洲
    • 2018-2030年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • ThermoFisher Scientific, Inc
    • Merck KGaA
    • Agilent Technologies
    • PerkinElmer, Inc
    • BD
    • Danaher
    • Bio-Rad Laboratories, Inc
    • BioTek Instruments, Inc
    • GE Healthcare
    • DeNovix Inc
Product Code: GVR-1-68038-592-2

Cell Counting Market Growth & Trends:

The global cell counting market size is expected to reach USD 15.46 billion by 2030, expanding at a CAGR of 8.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Rising prevalence of chronic diseases such as cancer, HIV, and Alzheimer's is the high impact rendering growth driver of the industry. Increasing prevalence of these diseases has surged clinical research activities, consequently propelling the demand for cell counting instruments and consumables. Government initiatives working to promote the development of cell therapeutics, wherein cell counting plays an imperative role, are also expanding growth prospects for the market.

An increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided a significant boost to growth. Growing number of proposed guidelines and recommendations for public and private laboratories to ensure high-quality standards and facilitate the generation of accurate results are likely to improve the adoption of instruments over the coming years. For instance, in May 2021, the International Society for Stem Cell Research updated guidelines for the development of cell-based therapy and research. The proposed guidelines focus on all stages of R&D and improve the quality of preclinical studies.

Technological advancements in these devices are also broadening growth prospects of the market. One of the promising technological advancements in differential cell counting is the ability to recognize blasts, immunoplatelet counting, detection of blasts, and reticulocyte fractions and stem cell counting with greater accuracy. The advent of CD4+ T-cell counting technology has proven to be very useful as an indicator of immune responses and has been adopted to evaluate the success or failure of Anti-retroviral Therapy (ARV). Dedicated cytometers are present in the market to perform CD4+ and CD8+ T-cell enumeration, such as the FACSCount by Becton Dickinson is based on T-cell counting technology.

The COVID-19 pandemic is anticipated to positively impact industry growth. WBC count of the COVID-19 patient during admission is significantly correlated with the death of patients. A higher level of white blood count should be given further care in the COVID-19 treatment. The growing importance of cell count in patients suffering from COVID-19 has augmented the growth of the industry during the pandemic.

The development of enhanced informatics solutions and improved image analysis instruments such as optical or fluorescence microscopes have fueled the growth prospects of this market. These instruments are being increasingly adopted in low sample throughput laboratories and settings with limited resources, which is highly prevalent in developing economies, thereby broadening the scope for growth of the industry.

On the other hand, limited availability of skilled professionals is the critical growth-restraining factor of the market. The lack of skilled professionals can be attributed to a lack of training facilities and high training costs. In order to improve this scenario, industry players are required to participate in the generation of training programs for software developed by these companies and encourage healthcare professionals and researchers to operate cell counting software. Moreover, the lack of standardization of these software tools also plays a key role in restricting researchers and healthcare professionals as every software differ in user interface.

Cell Counting Market Report Highlights:

  • By product, consumables and accessories segment accounted for the largest revenue share of 54.14% in 2022 and is expected to grow at the fastest CAGR of 8.4% over the forecast period
  • In the consumables and accessories segment, reagents held the largest revenue share of 56.3% in 2022. The large revenue share is attributed to the repeat purchase of these products for use during spectrophotometry, flow cytometry, and automated cell counting
  • The microplates sub-segment is poised to expand at the fastest CAGR during the forecast period. Microplates are usually used for analyzing very low concentration samples. The increased consumption of these plates is attributed to the repeated need to use fresh plates for analyzing a new sample to prevent contamination
  • In the instruments segment, automated cell counters are anticipated to grow at an exponential rate during the forecast period. Benefits such as short testing time, reduced error occurrence, and inter-operator variability are expected to further increase the demand for automated counters
  • By application, the complete blood count segment held the largest revenue share of 59.1% in 2022. The large revenue share can be attributed to increasing incidence of blood disorders
  • In the end-use segment, research and academic institutes accounted for the largest revenue share of 39.6% in2022 owing to growing number of government initiatives focused on promoting R&D in various toxicology studies
  • Pharmaceutical and biotechnology companies are anticipated to grow at the fastest CAGR of 9.0% during the forecast period
  • North America held the largest revenue share of over 37.6% owing to the increasing focus on biomedical and cancer research
  • Asia Pacific is expected to grow at the fastest CAGR of 10.3% over the forecast period owing to the large presence of clinical research organizations and biopharmaceutical companies in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cell Counting Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. Cell Counting Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic Landscape

Chapter 4. Cell Counting Market: Product Type Estimates & Trend Analysis

  • 4.1. Cell Counting Market: Key Takeaways
  • 4.2. Cell Counting Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Instruments
    • 4.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Spectrophotometers
      • 4.3.2.1. Spectrophotometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Flow cytometers
      • 4.3.3.1. Flow cytometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Hemocytometers
      • 4.3.4.1. Hemocytometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Automated cell counters
      • 4.3.5.1. Automated cell counters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.6. Microscopes
      • 4.3.6.1. Microscopes market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Consumable & Accessories
      • 4.4.1.1. Consumable & Accessories market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Reagents
      • 4.4.2.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Microplates
      • 4.4.3.1. Microplates market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cell Counting Market: Application Estimates & Trend Analysis

  • 5.1. Cell Counting Market: Key Takeaways
  • 5.2. Cell Counting Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Complete Blood Count
    • 5.3.1. Complete blood count market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Stem Cell Research
    • 5.4.1. Stem cell research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Cell-Based Therapeutics
    • 5.5.1. Cell-based therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Bioprocessing
    • 5.6.1. Bioprocessing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Toxicology
    • 5.7.1. Toxicology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cell Counting Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Cell Counting Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. U.K.
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. ThermoFisher Scientific, Inc
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Merck KGaA
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Agilent Technologies
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. PerkinElmer, Inc
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. BD
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Danaher
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Bio-Rad Laboratories, Inc
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. BioTek Instruments, Inc
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. GE Healthcare
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. DeNovix Inc
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 23 France cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 24 France cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 44 China cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 45 China cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 46 China cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 51 India cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 52 India cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Thailand cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 54 Thailand cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 55 Thailand cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Latin America cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 60 Latin America cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 61 Latin America cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 63 Brazil cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 64 Brazil cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 65 Brazil cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Mexico cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 67 Mexico cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 68 Mexico cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Argentina cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 70 Argentina cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 71 Argentina cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Middle East and Africa cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 73 Middle East and Africa cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 74 Middle East and Africa cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 76 South Africa cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 77 South Africa cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 78 South Africa cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 UAE cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 83 UAE cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 84 UAE cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Kuwait cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 86 Kuwait cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 87 Kuwait cell counting market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cell counting: Market outlook
  • Fig. 9 Cell counting: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Cell counting market driver impact
  • Fig. 15 Cell counting market restraint impact
  • Fig. 16 Cell counting market strategic initiatives analysis
  • Fig. 17 Cell counting market: Product type movement analysis
  • Fig. 18 Cell counting market: Product type outlook and key takeaways
  • Fig. 19 Instruments market estimates and forecasts, 2018 - 2030
  • Fig. 20 Consumables & accessories market estimates and forecasts, 2018 - 2030
  • Fig. 21 Cell counting market: Application movement analysis
  • Fig. 22 Cell counting market: Application outlook and key takeaways
  • Fig. 23 Complete blood count market estimates and forecasts, 2018 - 2030
  • Fig. 24 Stem cell research market estimates and forecasts, 2018 - 2030
  • Fig. 25 Cell-based therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 26 Bioprocessing market estimates and forecasts, 2018 - 2030
  • Fig. 27 Toxicology market estimates and forecasts, 2018 - 2030
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030
  • Fig. 29 Cell counting market: End-use movement analysis
  • Fig. 30 Cell counting market: End-use outlook and key takeaways
  • Fig. 31 Hospitals & diagnostic laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 32 Research & academic Institutes market estimates and forecasts, 2018 - 2030
  • Fig. 33 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030
  • Fig. 35 Global cell counting market: Regional movement analysis
  • Fig. 36 Global cell counting market: Regional outlook and key takeaways
  • Fig. 37 North America market estimates and forecasts, 2018 - 2030
  • Fig. 38 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 39 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 40 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 41 U.K. market estimates and forecasts, 2018 - 2030
  • Fig. 42 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 43 France market estimates and forecasts, 2018 - 2030
  • Fig. 44 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 45 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 46 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 47 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 48 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 50 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 51 China market estimates and forecasts, 2018 - 2030
  • Fig. 52 India market estimates and forecasts, 2018 - 2030
  • Fig. 53 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 54 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 55 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 56 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 57 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 58 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 59 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 60 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 61 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 62 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 63 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030